On May 19, 2025, vTv Therapeutics Inc. announced the appointment of Michael Tung as the new Chief Financial Officer with a base salary of $450,000 and stock options for 45,000 shares. His expertise includes over 20 years in financial management and strategic leadership in the life sciences sector.